Insider Trading activities of Biomarin Pharmaceutical Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $386,813,001.
The total value of stock option exercises since 2005 is $107,469,640.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biomarin Pharmaceutical Inc (BMRN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 0 $0 44,225 $3,978,648 42,989 $1,109,327
2017-05 0 $0 47,193 $4,376,722 50,655 $1,010,627
2017-04 0 $0 10,000 $948,600 13,000 $216,468
2017-03 0 $0 55,418 $5,104,844 33,500 $850,550
2017-02 0 $0 45,000 $4,139,850 45,000 $2,290,350
2017-01 0 $0 31,000 $2,724,720 26,000 $450,578
2016-12 0 $0 8,000 $668,760 8,000 $138,640
2016-11 0 $0 368,657 $31,735,869 348,657 $8,157,575
2016-10 0 $0 225,791 $18,849,073 225,791 $4,704,174
2016-09 0 $0 262,085 $24,730,339 243,618 $7,498,354
2016-08 0 $0 63,120 $5,880,505 56,666 $1,128,171
2016-07 0 $0 51,333 $4,771,291 51,822 $963,289
2016-06 0 $0 129,397 $10,443,194 124,998 $2,192,463
2016-05 0 $0 145,768 $12,305,697 138,396 $3,224,252
2016-04 0 $0 0 $0 3,000 $43,170
2016-03 0 $0 17,874 $1,523,767 0 $0
2016-02 0 $0 7,500 $600,000 7,500 $289,425
2015-12 0 $0 1,362 $136,200 0 $0
2015-11 0 $0 36,076 $3,775,304 35,000 $1,200,599
2015-10 0 $0 1,000 $108,241 0 $0
2015-09 0 $0 1,000 $131,432 15,000 $322,650
2015-08 0 $0 1,500 $202,083 0 $0
2015-07 0 $0 4,500 $658,599 3,000 $189,300
2015-06 0 $0 9,197 $1,132,782 0 $0
2015-05 0 $0 144,799 $17,960,963 56,849 $1,173,278
2015-04 0 $0 26,052 $3,140,125 22,546 $145,647
2015-03 0 $0 183,803 $20,976,250 163,051 $3,632,357
2015-01 0 $0 2,000 $188,286 0 $0
2014-12 0 $0 38,450 $3,486,374 36,450 $955,257
2014-11 0 $0 53,447 $4,697,929 46,000 $1,037,940
2014-10 0 $0 94,425 $7,692,840 94,425 $2,718,809
2014-09 0 $0 33,554 $2,341,703 33,536 $1,002,159
2014-08 0 $0 17,229 $1,137,651 15,000 $280,050
2014-07 0 $0 2,229 $142,656 0 $0
2014-06 0 $0 2,377 $144,200 0 $0
2014-05 0 $0 14,517 $835,233 0 $0
2014-03 0 $0 25,382 $2,009,360 27,370 $770,451
2014-02 0 $0 38,000 $2,916,970 34,000 $697,260
2014-01 0 $0 20,916 $1,431,756 20,000 $259,800
2013-12 0 $0 92,426 $6,437,860 74,526 $1,970,425
2013-11 0 $0 5,099 $318,032 10,000 $129,900
2013-10 0 $0 15,000 $962,902 12,000 $155,880
2013-09 0 $0 51,000 $3,729,064 51,000 $1,028,720
2013-08 0 $0 1,000 $64,364 1,000 $12,990
2013-07 0 $0 14,066 $843,061 12,000 $187,188
2013-06 0 $0 1,591 $92,799 45,000 $1,679,849
2013-05 0 $0 243,590 $16,594,563 225,831 $4,603,936
2013-04 0 $0 49,102 $3,137,955 48,102 $693,782
2013-03 0 $0 71,141 $4,305,011 68,126 $1,078,025
2013-02 0 $0 77,003 $4,327,513 75,503 $1,232,701
2013-01 0 $0 121,324 $6,578,490 107,324 $2,326,181
2012-12 0 $0 62,415 $3,038,034 54,756 $741,033
2012-11 0 $0 409,971 $19,513,489 370,722 $6,587,545
2012-10 0 $0 39,665 $1,658,284 36,665 $544,056
2012-09 0 $0 16,665 $647,721 15,665 $187,597
2012-08 0 $0 47,665 $1,797,044 37,665 $535,017
2012-07 0 $0 118,281 $4,739,697 118,281 $1,977,035
2012-06 0 $0 7,665 $274,180 8,915 $109,964
2012-05 0 $0 265,671 $9,928,453 267,703 $3,409,494
2012-04 0 $0 36,544 $1,270,139 26,853 $285,655
2012-03 0 $0 17,855 $618,010 16,855 $130,291
2012-02 0 $0 218,703 $7,691,550 237,703 $3,228,885
2012-01 0 $0 6,854 $238,583 6,854 $96,823
2011-12 0 $0 1,854 $62,646 1,854 $33,223
2011-11 0 $0 4,615 $151,482 4,355 $69,216
2011-10 0 $0 39,607 $1,354,767 39,607 $626,028
2011-09 0 $0 23,733 $749,111 22,733 $391,565
2011-08 0 $0 53,577 $1,607,974 49,577 $532,560
2011-07 0 $0 50,866 $1,504,767 49,866 $807,320
2011-06 0 $0 4,472 $119,418 16,895 $32,784
2011-05 0 $0 99,608 $2,702,288 108,058 $1,446,241
2011-04 0 $0 21,819 $581,565 13,654 $167,147
2011-03 0 $0 7,772 $189,100 7,772 $93,152
2011-02 0 $0 18,912 $476,175 18,912 $147,194
2011-01 0 $0 5,271 $139,653 1,771 $22,701
2010-12 0 $0 12,313 $341,988 12,313 $131,902
2010-11 0 $0 126,394 $3,294,091 111,437 $1,381,669
2010-10 0 $0 82,479 $2,094,260 82,479 $1,091,944
2010-09 0 $0 48,709 $1,072,279 38,709 $453,555
2010-08 0 $0 25,490 $526,953 19,833 $184,744
2010-07 0 $0 3,333 $69,160 3,333 $44,691
2010-06 0 $0 1,676 $32,910 26,084 $9,215
2010-05 0 $0 4,072 $90,417 32,834 $27,083
2010-04 0 $0 7,082 $169,970 7,082 $82,305
2010-03 0 $0 231,894 $5,167,130 190,478 $3,813,628
2010-02 800 $16,062 377 $7,917 377 $4,425
2010-01 0 $0 21,143 $443,625 20,143 $285,149
2009-12 0 $0 22,500 $390,494 21,000 $154,140
2009-08 0 $0 4,177 $66,464 177 $1,085
2009-07 0 $0 456 $6,332 1,250 $0
2009-06 3,500 $49,180 2,863 $41,528 16,750 $0
2009-03 13,000 $136,474 7,897 $92,394 7,897 $50,777
2009-02 10,000 $120,780 17,000 $325,363 17,000 $109,310
2009-01 0 $0 19,679 $354,645 19,679 $140,038
2008-12 6,400 $105,495 28,177 $454,898 17,177 $105,295
2008-11 0 $0 75,177 $1,201,645 33,177 $401,111
2008-10 503 $6,716 18,177 $476,456 18,177 $111,425
2008-09 0 $0 31,996 $974,263 19,996 $323,338
2008-08 0 $0 20,469 $648,787 7,019 $62,349
2008-07 0 $0 70,646 $2,103,891 41,996 $585,158
2008-06 0 $0 28,143 $1,024,770 36,143 $290,735
2008-05 0 $0 112,176 $4,266,543 94,300 $844,289
2008-04 9,849 $105,960 115,479 $4,207,078 153,057 $799,223
2008-03 0 $0 489,028 $17,346,767 397,956 $3,672,988
2008-02 0 $0 147,462 $5,572,934 118,625 $1,063,920
2008-01 0 $0 35,490 $1,282,494 35,490 $245,758
2007-12 0 $0 21,114 $753,542 21,114 $171,399
2007-11 0 $0 2,365 $61,052 2,365 $26,383
2007-10 4,695 $32,483 51,371 $1,319,911 51,371 $450,827
2007-09 0 $0 238,442 $5,460,778 171,149 $1,143,929
2007-08 0 $0 127,019 $2,584,367 135,019 $945,187
2007-07 0 $0 14,500 $263,818 12,500 $50,000
2007-06 0 $0 16,045 $291,731 11,045 $73,043
2007-05 0 $0 18,500 $313,556 15,000 $96,900
2007-04 12,892 $74,852 19,000 $332,353 17,500 $82,300
2007-03 0 $0 13,500 $221,188 0 $0
2007-02 0 $0 42,000 $777,820 28,000 $187,090
2007-01 0 $0 12,500 $203,700 12,500 $50,000
2006-12 2,100 $37,554 14,500 $261,000 14,500 $117,450
2006-11 0 $0 17,500 $285,125 17,500 $85,800
2006-10 12,893 $60,411 0 $0 0 $0
2006-08 2,500 $37,100 98,500 $1,526,147 128,500 $929,790
2006-07 1,500 $21,658 0 $0 20,000 $94,400
2006-06 1,500 $19,575 0 $0 0 $0
2006-05 5,500 $67,657 0 $0 0 $0
2006-04 1,500 $20,010 0 $0 0 $0
2006-03 1,500 $19,489 28,000 $391,000 28,000 $188,670
2006-02 5,000 $62,940 23,500 $286,280 23,500 $132,650
2006-01 1,500 $16,177 2,500 $30,500 52,500 $217,500
2005-12 2,500 $25,145 40,571 $420,417 0 $0
2005-11 1,500 $12,554 40,571 $405,710 0 $0
2005-10 3,500 $27,265 0 $0 0 $0
2005-09 4,500 $38,587 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-19 Fuchs Henry J (President, Worldwide R&D) Sale 603 90.00 54,270
2017-06-19 Fuchs Henry J (President, Worldwide R&D) Option Ex 603 37.46 22,588
2017-06-16 Lawlis V Bryan Sale 3,750 90.00 337,500
2017-06-16 Lawlis V Bryan Option Ex 3,750 38.59 144,712
2017-06-16 Fuchs Henry J (President, Worldwide R&D) Sale 14,397 90.00 1,295,730
2017-06-16 Fuchs Henry J (President, Worldwide R&D) Option Ex 14,397 31.98 460,344
2017-06-09 Davis George Eric (EVP, General Counsel) Option Ex 9,239 24.00 221,736
2017-06-07 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,004 89.61 89,968
2017-06-05 Davis George Eric (EVP, General Counsel) Sale 9,471 91.04 862,230
2017-06-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 90.56 452,800
2017-06-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-06-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 89.70 448,500
2017-06-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-06-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 87.53 437,650
2017-06-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-05-31 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,423 88.29 655,376
2017-05-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,423 17.33 128,640
2017-05-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 88.38 441,900
2017-05-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-05-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 91.73 458,650
2017-05-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-05-16 Davis George Eric (EVP, General Counsel) Option Ex 1,146 14.39 16,490
2017-05-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 89.23 446,150
2017-05-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-05-08 Mueller Brian (SVP, Corporate Controller) Sale 7,482 92.17 689,615
2017-05-08 Mueller Brian (SVP, Corporate Controller) Option Ex 2,600 21.51 55,926
2017-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 93.17 465,850
2017-05-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-05-05 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 4,486 99.00 444,114
2017-05-05 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Option Ex 4,486 33.41 149,877
2017-05-05 Davis George Eric (EVP, General Counsel) Sale 2,500 100.34 250,852
2017-05-05 Davis George Eric (EVP, General Counsel) Option Ex 2,500 38.59 96,475
2017-05-05 Meier Richard A Option Ex 7,500 17.33 129,974
2017-05-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 99.00 495,000
2017-05-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-05-02 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 302 96.74 29,215
2017-04-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 95.72 478,600
2017-04-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-04-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 94.00 470,000
2017-04-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-04-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2017-03-29 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 3,890 89.15 346,793
2017-03-16 Davis George Eric (EVP, General Counsel) Sale 2,238 91.96 205,806
2017-03-16 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,989 91.96 182,908
2017-03-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 91.96 459,799
2017-03-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 71.33 356,650
2017-03-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 91.42 457,100
2017-03-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-03-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 92.68 463,400
2017-03-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-03-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 91.09 455,450
2017-03-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-03-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 6,000 90.18 541,080
2017-03-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 6,000 17.33 103,979
2017-03-07 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 5,000 90.56 452,800
2017-03-06 Davis George Eric (EVP, General Counsel) Sale 1,498 93.32 139,793
2017-03-06 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 2,303 93.32 214,915
2017-03-01 Lawlis V Bryan Sale 7,500 95.00 712,500
2017-03-01 Lawlis V Bryan Option Ex 7,500 17.33 129,974
2017-03-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 5,000 94.50 472,500
2017-02-28 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 30,000 94.00 2,820,000
2017-02-28 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 30,000 63.10 1,893,000
2017-02-24 Fuchs Henry J (President, Worldwide R&D) Sale 15,000 87.99 1,319,850
2017-02-24 Fuchs Henry J (President, Worldwide R&D) Option Ex 15,000 26.49 397,350
2017-01-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 84.00 420,000
2017-01-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-01-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 84.44 422,200
2017-01-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-01-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.84 359,360
2017-01-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2017-01-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 91.31 365,240
2017-01-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2017-01-09 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 5,000 90.00 450,000
2017-01-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.79 359,160
2017-01-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2017-01-06 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 87.19 348,760
2017-01-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2016-12-30 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 83.35 333,400
2016-12-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2016-12-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 83.84 335,360
2016-12-29 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2016-11-25 Fuchs Henry J (President, Worldwide R&D) Sale 15,000 87.40 1,310,985
2016-11-25 Fuchs Henry J (President, Worldwide R&D) Option Ex 15,000 26.49 397,350
2016-11-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 69,743 85.69 5,976,486
2016-11-22 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 69,743 26.49 1,847,492
2016-11-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 69,744 87.56 6,106,505
2016-11-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 69,744 26.49 1,847,518
2016-11-18 Davis George Eric (EVP, General Counsel) Sale 5,000 90.42 452,100
2016-11-18 Davis George Eric (EVP, General Counsel) Option Ex 5,000 38.59 192,950
2016-11-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,670 90.97 3,790,803
2016-11-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,670 17.54 730,891
2016-11-09 Lawlis V Bryan Sale 7,500 95.00 712,500
2016-11-09 Lawlis V Bryan Option Ex 7,500 17.33 129,974
2016-11-09 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 20,000 90.61 1,812,200
2016-11-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 70,000 82.83 5,797,820
2016-11-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 21.51 1,505,700
2016-11-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 70,000 82.52 5,776,470
2016-11-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 21.51 1,505,700
2016-10-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 60,000 81.27 4,876,020
2016-10-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 60,000 14.39 863,400
2016-10-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 60,000 81.34 4,880,460
2016-10-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 60,000 14.39 863,400
2016-10-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,666 84.39 3,516,235
2016-10-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,666 17.54 730,821
2016-10-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 11,000 86.89 955,812
2016-10-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 11,000 17.86 196,460
2016-10-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 53,125 86.97 4,620,546
2016-10-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 53,125 38.59 2,050,093
2016-09-30 Bienaime Jean Jacques (Chief Executive Officer) Sale 53,125 92.02 4,888,775
2016-09-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 53,125 38.59 2,050,093
2016-09-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 53,125 93.64 4,974,890
2016-09-29 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 53,125 38.59 2,050,093
2016-09-27 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 18,467 95.61 1,765,648
2016-09-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 94,791 95.61 9,062,683
2016-09-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 94,791 28.07 2,660,309
2016-09-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 42,577 94.85 4,038,343
2016-09-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 42,577 17.33 737,859
2016-08-26 Fuchs Henry J (EVP, Chief Medical Officer) Sale 15,000 95.06 1,425,930
2016-08-26 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 15,000 26.49 397,350
2016-08-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,666 91.49 3,811,855
2016-08-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,666 17.54 730,821
2016-08-01 Mueller Brian (VP, Corporate Controller) Sale 287 100.00 28,700
2016-08-01 Davis George Eric (EVP, General Counsel) Sale 2,167 100.00 216,700
2016-08-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,000 99.33 397,320
2016-07-27 Lawlis V Bryan Sale 1,100 95.39 104,926
2016-07-27 Lawlis V Bryan Option Ex 1,100 17.33 19,062
2016-07-22 Lawlis V Bryan Sale 6,400 95.01 608,064
2016-07-22 Lawlis V Bryan Option Ex 6,400 17.33 110,911
2016-07-18 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,666 92.72 3,863,271
2016-07-18 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,666 17.54 730,821
2016-07-14 Davis George Eric (EVP, General Counsel) Option Ex 2,656 38.59 102,495
2016-07-07 Davis George Eric (EVP, General Counsel) Sale 2,167 90.00 195,030
2016-06-20 Lawlis V Bryan Sale 1,650 82.77 136,569
2016-06-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 83,332 80.55 6,712,392
2016-06-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 83,332 17.54 1,461,642
2016-06-06 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,649 89.14 146,991
2016-05-31 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 20,841 89.67 1,868,916
2016-05-31 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 16,896 39.06 659,957
2016-05-26 Fuchs Henry J (EVP, Chief Medical Officer) Sale 15,000 87.69 1,315,350
2016-05-26 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 15,000 26.49 397,350
2016-05-23 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 3,769 87.08 328,185
2016-05-18 Baffi Robert (EVP, Technical Operations) Sale 5,000 87.05 435,250
2016-05-10 Davis George Eric (EVP, General Counsel) Sale 4,658 86.32 402,078
2016-05-09 Davis George Eric (EVP, General Counsel) Sale 10,000 84.55 845,530
2016-05-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 50,000 80.15 4,007,450
2016-05-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 24.18 1,692,810
2016-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 36,500 85.01 3,102,938
2016-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 36,500 12.99 474,135
2016-04-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 14.39 21,585
2016-04-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 14.39 21,585

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.